Among adults with type 2 diabetes who started noninsulin second-line therapy, most modified treatment within 1 year. Discontinuation was by far the most common modification.
David T. Liss, PhD
Advertisement
Articles by David T. Liss, PhD
Adults with type 2 diabetes who received nonsulfonylurea medications had relative increases in total costs. Receiving newer medication classes led to relatively decreased medical costs.
Patients with rheumatoid arthritis self-report a moderate rate of any previous pneumococcal vaccination (54%) and a very low rate of herpes zoster vaccination (8%).
This study investigated healthcare quality, utilization, and costs among patients with common chronic illnesses in a patient-centered medical home prototype redesign.
Advertisement
Latest Updated Articles
- Costs for Commercially Insured Adults Prescribed Second-line Diabetes Medications
Published: March 9th 2021 | Updated:
Treatment Modification After Initiating Second-Line Medication for Type 2 DiabetesPublished: December 12th 2023 | Updated:
- Understanding Vaccination Rates and Attitudes Among Patients With Rheumatoid Arthritis
Published: March 17th 2016 | Updated:
- Outcomes Among Chronically Ill Adults in a Medical Home Prototype
Published: October 22nd 2013 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Rural-Urban Disparities in Colorectal Cancer Screening Persist
2
Medicaid Work Rules Could Strain Hospitals: Laxmi Patel
3
Insurance Coverage Improves for Same-Sex Couples, Yet Disparities Persist
4
Identifying Barriers to Colorectal Cancer Screening for People With IDD
5
